|
Summary Information: Fusion Pharmaceuticals Inc. Common Shares NASDAQ:FUSN |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial. The Company is advancing a pipeline of targeted radiopharmaceutical cancer therapies for a broad array of tumor types based upon its proprietary platform technology.
__The following are links to various summary and news pages for __Fusion Pharmaceuticals Inc. Common Shares [ FUSN ]. __Note: Some Links might not have information for the company. |
|